Antidepressants and psychostimulants in pediatric populations: Is there an association with mania?

Pediatric Drugs

Volumn 13, Issue 4, 2011, Pages 225-243

  Goldsmith, Michelle ^a   Singh, Manpreet ^a   Chang, Kiki ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressants; Attention deficit hyperactivity disorder; Bipolar disorders; Central nervous system stimulants; Children; Manic episodes; Serotonin uptake inhibitors

Indexed keywords

ANTIDEPRESSANT AGENT; ATOMOXETINE; FLUOXETINE; METHYLPHENIDATE; PAROXETINE; PLACEBO; PSYCHOSTIMULANT AGENT; SEROTONIN UPTAKE INHIBITOR; VALPROATE SEMISODIUM;

ANXIETY; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; DEPRESSION; HUMAN; MAJOR DEPRESSION; MANIA; MONOTHERAPY; ONSET AGE; PRIORITY JOURNAL; REVIEW;

AGE FACTORS; AGE OF ONSET; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DEPRESSIVE DISORDER; HUMANS; RISK FACTORS;

EID: 79959621221     PISSN: 11745878     EISSN: 11792019     Source Type: Journal    
DOI: 10.2165/11591660-000000000-00000     Document Type: Review

References (101)

1. Zito JM, Safer DJ, DosReis S, et al. Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med 2003 Jan; 157 (1): 17-25 (Pubitemid 36343413)
2. Greenhill L, Beyer DH, Finkleson J, et al. Guidelines and algorithms for the use of methylphenidate in children with attention-deficit/hyperactivity disorder. J Atten Disord 2002; 6 Suppl. 1: S89-100
3. Pliszka S, Dodson WW, Spencer TJ. Current treatments of attentiondeficit/ hyperactivity disorder. CNS Spectr 2000 May; 5 (5 Suppl. 3): S1-7
4. Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007; 46 (7): 894-921
5. Hughes C, Emslie G, Crismon M, et al. Texas childrens medication algorithm project: update from Texas consensus conference panel on medication treatment of childhood major depressive disorder. J AmAcad Child Adolesc Psychiatry 2007; 46 (6): 667-86 (Pubitemid 46816821)
6. Boylan K, Romero S, Birmaher B. Psychopharmacologic treatment of pediatric major depressive disorder. Psychopharmacology 2007; 191 (1): 27-38 (Pubitemid 46294941)
7. American Psychiatric Association. Diagnostic criteria from DSM-IV-TR. Washington, DC: American Psychiatric Association, 2000
8. Carlson GA, Kelly KL. Manic symptoms in psychiatrically hospitalized children: what do they mean? J Affect Disord 1998 Nov; 51 (2): 123-35 (Pubitemid 29101686)
9. Carlson GA, Loney J, Salisbury H, et al. Stimulant treatment in young boys with symptoms suggesting childhood mania: a report from a longitudinal study. J Child Adolesc Psychopharmacol 2000 Fall; 10 (3): 175-84
10. Galanter CA, Carlson GA, Jensen PS, et al. Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. J Child Adolesc Psychopharmacol 2003 Summer; 13 (2): 123-36 (Pubitemid 37484232)
11. Arnold L, Abikoff H, Cantwell D, et al. NIMH collaborative multimodal treatment study of children with ADHD (MTA): design, methodology, and protocol evolution. J Atten Disord 1997; 2 (3): 141-58 (Pubitemid 127729776)
12. Achenbach T. Child behavior checklist/4-18. Burlington (VT): University of Vermont, Department of Psychiatry, 1991
13. Shaffer D, Fisher P, Dulcan M, et al. The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA study. J Am Acad Child Adolesc Psychiatry 1996; 35 (7): 865-77 (Pubitemid 26230920)
14. Tillman R, Geller B. Controlled study of switching from attentiondeficit/ hyperactivity disorder to a prepubertal and early adolescent bipolar I disorder phenotype during 6-year prospective follow-up: rate, risk, and predictors. Dev Psychopathol 2006 Fall; 18 (4): 1037-53 (Pubitemid 46389729)
15. Shaffer D, Gould MS, Brasic J, et al. A childrens global assessment scale (CGAS). Arch Gen Psychiatry 1983 Nov; 40 (11): 1228-31 (Pubitemid 13015019)
16. Scheffer R, Kowatch R, Carmody T, et al. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry 2005; 162 (1): 58-64 (Pubitemid 40095673)
17. Guy W, Bonato R. CGI: Clinical global impressions. ECDEU assessment manual for psychopharmacology. Chevy Chase (MD): National Institute of Mental Health, 1976: 217-22
18. Young R, Biggs J, Ziegler V, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133 (5): 429-35 (Pubitemid 9006756)
19. Findling RL, Short EJ, McNamara NK, et al. Methylphenidate in the treatment of children and adolescents with bipolar disorder and attentiondeficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007; 46 (11): 1445-53 (Pubitemid 351338965)
20. Poznanski E, Mokros H, Services WP. Childrens Depression Rating Scale. Rev. (CDRS-R). Los Angeles (CA): Western Psychological Services, 1996
21. Chang K, Nayar D, Howe M, et al. Atomoxetine as an adjunct therapy in the treatment of co-morbid attention-deficit/hyperactivity disorder in children and adolescents with bipolar I or II disorder. J Child Adolesc Psychopharmacol 2009; 19 (5): 547-51
22. DuPaul GJ, Power TJ, Anastopoulos AD, et al. ADHD rating scale-IV: checklists, norms, and clinical interpretation. New York: Guilford, 1998
23. Zeni CP, Tramontina S, Ketzer CR, et al. Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attentiondeficit/ hyperactivity disorder: a randomized crossover trial. J Child Adolesc Psychopharmacol 2009 Oct; 19 (5): 553-61
24. Faedda G. Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review. J Affect Disord 2004; 82 (1): 149-58 (Pubitemid 39311981)
25. Findling RL, Lingler J, Rowles BM, et al. A pilot pharmacotherapy trial for depressed youths at high genetic risk for bipolarity. J Child Adolesc Psychopharmacol 2008; 18 (6): 615-21
26. Baumer F, Howe M, Gallelli K, et al. A pilot study of antidepressant-induced mania in pediatric bipolar disorder: characteristics, risk factors, and the serotonin transporter gene. Biol Psychiatry 2006; 60 (9): 1005-12 (Pubitemid 44584215)
27. Biederman J, Mick E, Spencer TJ, et al. Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young. J Child Adolesc Psychopharmacol 2000 Fall; 10 (3): 185-92
28. DelBello M, Soutullo C, Hendricks W, et al. Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset. Bipolar Disord 2001; 3 (2): 53-7 (Pubitemid 32492590)
29. Geller B, WilliamsM, Zimerman B, et al. Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-UKSADS). St Louis (MO): Washington University, 1996
30. Martin A, Young C, Leckman JF, et al. Age effects on antidepressant- induced manic conversion. Arch Pediatr Adolesc Med 2004 Aug; 158 (8): 773-80 (Pubitemid 39025076)
31. Chang K, Saxena K, Howe M, et al. Psychotropic medication exposure and age at onset of bipolar disorder in offspring of parents with bipolar disorder. J Child Adolesc Psychopharmacol 2010; 20 (1): 25-32
32. Koehler-Troy C, Strober M, Malenbaum R. Methylphenidate-induced mania in a prepubertal child. J Clin Psychiatry 1986 Nov; 47 (11): 566-7 (Pubitemid 17187519)
33. Schmidt K, Delaney MA, Jensen M, et al. Methylphenidate challenge in a manic boy. Biol Psychiatry 1986 Sep; 21 (11): 1107-9
34. Tversky A, Kahneman D. Availability: a heuristic for judging frequency and probability. Cogn Psychol 1973; 5: 207-32
35. Bornstein BH, Emler AC. Rationality in medical decision making: a review of the literature on doctors decision-making biases. J Eval Clin Pract 2001 May; 7 (2): 97-107 (Pubitemid 32489003)
36. Geller B, Tillman R, Craney JL, et al. Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Arch Gen Psychiatry 2004 May; 61 (5): 459-67 (Pubitemid 38620844)
37. Singh MK, DelBello MP, Kowatch RA, et al. Co-occurrence of bipolar and attention-deficit hyperactivity disorders in children. Bipolar Disord 2006 Dec; 8 (6): 710-20 (Pubitemid 44824711)
38. Thorndike RL. Personnel selection: test and measurement techniques. New York: John Wiley, 1949
39. PearsonK.Mathematical contributions to the theory of evolution. XI: On the influence of natural selection on the variability and correlation of organs. Philosophical transactions of the Royal Society of London Series A, containing papers of a mathematical or physical character. 1903; 200: 1-66
40. Kowatch RA, Fristad M, Birmaher B, et al. Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2005 Mar; 44 (3): 213-35 (Pubitemid 40299835)
41. Soutullo CA, DelBello MP, Ochsner JE, et al. Severity of bipolarity in hospitalized manic adolescents with history of stimulant or antidepressant treatment. J Affect Disord 2002 Aug; 70 (3): 323-7 (Pubitemid 34786649)
42. Joseph MF, Youngstrom EA, Soares JC. Antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors. Future Neurol 2009; 4 (1): 87-102
43. Peet M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994 Apr; 164 (4): 549-50 (Pubitemid 24141686)
44. Altshuler L, Post R, Leverich G, et al. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 152 (8): 1130-8
45. McClellan J, Kowatch R, Findling RL. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder [published erratum appears in J Am Acad Child Adolesc Psychiatry 2007; 46 (6): 786]. Work Group on Quality Issues. J Am Acad Child Adolesc Psychiatry 2007; 46 (1): 107-25
46. Goldberg JF, Truman CJ. Antidepressant-induced mania: an overview of current controversies. Bipolar Disord 2003 Dec; 5 (6): 407-20 (Pubitemid 38072243)
47. Hammad T. Results of the analysis of suicidality in pediatric trials of newer antidepressants. Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee September 13-14, 2004: Division of Neuropharmacological Drug Products Center for Drug Evaluation and Research [slide 96; online]. Available from URL: http://www.fda.gov/ohrms/dockets/ ac/04/slides/2004-4065S1-08-FDA-Hammad.ppt [Accessed 2011 May 26]
48. Cheung AH, Emslie GJ, Mayes TL. Review of the efficacy and safety of antidepressants in youth depression. J Child Psychol Psychiatry 2005; 46 (7): 735-54 (Pubitemid 40932958)
49. Carlson GA, Mick E. Drug-induced disinhibition in psychiatrically hospitalized children. J Child Adolesc Psychopharmacol 2003 Summer; 13 (2): 153-63 (Pubitemid 37484235)
50. Emslie G, Kratochvil C, Vitiello B, et al. Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006; 45 (12): 1440-55 (Pubitemid 44900917)
51. Emslie G, Kratochvil C, Vitiello B, et al. Treatment for Adolescents with Depression Study (TADS): safety results. J Am Acad Child Adolesc Psychiatry 2006 Dec; 45 (12): 1440-55 (Pubitemid 44900917)
52. Wilens TE, Biederman J, Kwon A, et al. A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors. J Child Adolesc Psychopharmacol 2003 Summer; 13 (2): 143-52 (Pubitemid 37484234)
53. Go FS, Malley EE, Birmaher B, et al. Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 1998; 8 (1): 73-80 (Pubitemid 28270781)
54. Masi G. Obsessive-compulsive bipolar comorbidity: focus on children and adolescents. J Affect Disord 2004; 78 (3): 175-83 (Pubitemid 38167735)
55. Brent DA. The rewards of reducing risk.Arch Pediatr Adolesc Med 2004 Aug; 158 (8): 824-5 (Pubitemid 39025084)
56. Emslie GJ, Rush AJ, Weinberg WA, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997 Nov; 54 (11): 1031-7 (Pubitemid 27476099)
57. Emslie GJ, Heiligenstein JH, Wagner KD, et al. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 2002 Oct; 41 (10): 1205-15 (Pubitemid 38338040)
58. Geller B, Cooper TB, Zimerman B, et al. Lithium for prepubertal depressed children with family history predictors of future bipolarity: a double-blind, placebo-controlled study. J Affect Disord 1998 Nov; 51 (2): 165-75 (Pubitemid 29101690)
59. DelBello MP, Chang K, Welge JA, et al. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. Bipolar Disord 2009 Aug; 11 (5): 483-93
60. Chang K, Dienes K, Blasey C, et al. Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms. J Clin Psychiatry 2003; 64 (8): 936-42 (Pubitemid 37022760)
61. DelBello M, Adler C, Whitsel R, et al. A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder. J Clin Psychiatry 2007; 68 (5): 781-8
62. Goldstein BI, Levitt AJ. Prevalence and correlates of bipolar I disorder among adults with primary youth-onset anxiety disorders. J Affect Disord 2007; 103 (1-3): 187-95 (Pubitemid 47454646)
63. Henin A, Biederman J, Mick E, et al. Childhood antecedent disorders to bipolar disorder in adults: a controlled study. J Affect Disord 2007; 99 (1-3): 51-7
64. Johnson JG, Cohen P, Brook JS. Associations between bipolar disorder and other psychiatric disorders during adolescence and early adulthood: a community-based longitudinal investigation. Am J Psychiatry 2000; 157 (10): 1679-81
65. Daray FM, Thommi SB, Ghaemi SN. The pharmacogenetics of antidepressant- induced mania: a systematic review and meta-analysis. Bipolar Disord 2010; 12 (7): 702-6
66. Biederman J, Mick E, Faraone SV, et al. Pediatric mania: a developmental subtype of bipolar disorder? Biol Psychiatry 2000 Sep 15; 48 (6): 458-66
67. Geller B, Fox L, Clark K. Rate and predictors of prepubertal bipolarity during follow-up of 6-to 12-year-old depressed children. J Am Acad Child Adolesc Psychiatry 1994; 33 (4): 461-8 (Pubitemid 24133064)
68. Henry C, Sorbara F, Lacoste J, et al. Antidepressant-induced mania in bipolar patients: identification of risk factors. J Clin Psychiatry 2001; 62 (4): 249-55 (Pubitemid 32428763)
69. Truman C, Goldberg J, Nassir Ghaemi S, et al. Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEPBD). J Clin Psychiatry 2007; 68 (10): 1472-9 (Pubitemid 350073393)
70. Wehr T, Goodwin F. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979; 36 (5): 555-9 (Pubitemid 9201187)
71. Goldberg J, Nassir Ghaemi S. Benefits and limitations of antidepressants and traditional mood stabilizers for treatment of bipolar depression. Bipolar Disord 2005; 7: 3-12
72. Sachs G, Printz D, Kahn D, et al. The expert consensus guideline series: medication treatment of bipolar disorder. Postgrad Med 2000; 1: 1-104
73. Salvadore G, Quiroz JA, Machado-Vieira R, et al. The neurobiology of the switch process in bipolar disorder. J Clin Psychiatry 2010; 71 (11): 1488-501
74. Faedda G, Baldessarini R, Glovinsky I, et al. Pediatric bipolar disorder: phenomenology and course of illness. Bipolar Disord 2004; 6 (4): 305-13 (Pubitemid 39077091)
75. Fitzmaurice G. Regression to the mean. Nutrition 2000 Jan; 16 (1): 80-1
76. Geller B, Craney JL, Bolhofner K, et al. Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2002 Jun; 159 (6): 927-33 (Pubitemid 34586936)
77. Chang K, Saxena K, Howe M. An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry 2006; 45 (3): 298-304
78. Patel N, DelBello M, Cecil K, et al. Lithium treatment effects on myoinositol in adolescents with bipolar depression. Biol Psychiatry 2006; 60 (9): 998-1004 (Pubitemid 44584217)
79. Reichart C. Earlier onset of bipolar disorder in children by antidepressants or stimulants? An hypothesis. J Affect Disord 2004; 78 (1): 81-4 (Pubitemid 37522086)
80. Chang K, Steiner H, Ketter T. Psychiatric phenomenology of child and adolescent bipolar offspring. J Am Acad Child Adolesc Psychiatry 2000; 39 (4): 453-60 (Pubitemid 30185540)
81. Akiskal H. Developmental pathways to bipolarity: are juvenile-onset depressions pre-bipolar? J Am Acad Child Adolesc Psychiatry 1995; 34 (6): 754-63
82. Geller B, Zimerman B, Williams M, et al. Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder. Am J Psychiatry 2001; 158 (1): 125-7 (Pubitemid 32047258)
83. DelBello MP, Carlson GA, Tohen M, et al. Rates and predictors of developing a manic or hypomanic episode 1 to 2 years following a first hospitalization for major depression with psychotic features. J Child Adolesc Psychopharmacol 2003 Summer; 13 (2): 173-85 (Pubitemid 37484237)
84. Cicero D, El-Mallakh R, Holman J, et al. Antidepressant exposure in bipolar children. Psychiatry 2003; 66 (4): 317-22 (Pubitemid 38129799)
85. Pagano M, Demeter C, Faber J, et al. Initiation of stimulant and antidepressant medication and clinical presentation in juvenile bipolar I disorder. Bipolar Disord 2008; 10 (2): 334-41 (Pubitemid 351637698)
86. Post R, Rubinow D, Ballenger J. Conditioning and sensitisation in the longitudinal course of affective illness. Br J Psychiatry 1986; 149 (2): 191-201 (Pubitemid 16076251)
87. Chang K, Howe M, Gallelli K, et al. Prevention of pediatric bipolar disorder. Ann N Y Acad Sci 2006; 1094 (1): 235-47
88. Chang K, Steiner H, Ketter T. Studies of offspring of parents with bipolar disorder.AmJMed Genet CSemin MedGenet 2003 Nov 15; 123C (1): 26-35
89. Carlson GA. The bottom line. J Child Adolesc Psychopharmacol 2003 Summer; 13 (2): 115-8 (Pubitemid 37484230)
90. Hellander M. Medication-induced mania: ethical issues and the need for more research. J Child Adolesc Psychopharmacol 2003 Summer; 13 (2): 199 (Pubitemid 37484239)
91. Michelson D, Faries D, Wernicke J, et al. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics 2001; 108 (5): e83
92. Cheung A, Dewa C, Levitt A. Clinical review of mania, hostility and suiciderelated events in children and adolescents treated with antidepressants. Paediatr Child Health 2005; 10 (8): 457-63 (Pubitemid 41719708)
93. Safer DJ, Zito JM. Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents. J Child Adolesc Psychopharmacol 2006 Feb-Apr; 16 (1-2): 159-69
94. Strober M, Carlson G. Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three-to four-year prospective follow-up investigation. Arch Gen Psychiatry 1982; 39 (5): 549-55 (Pubitemid 12125546)
95. Rao U, Ryan N, Birmaher B, et al. Unipolar depression in adolescents: clinical outcome in adulthood. J Am Acad Child Adolesc Psychiatry 1995; 34 (5): 566-78
96. Kovacs M. Presentation and course of major depressive disorder during childhood and later years of the life span. J Am Acad Child Adolesc Psychiatry 1996; 35 (6): 705-15 (Pubitemid 26174604)
97. Chang KD. Challenges in the diagnosis and treatment of pediatric bipolar depression. Dialogues Clin Neurosci 2009; 11 (1): 73-80
98. Miklowitz DJ, Axelson DA, Birmaher B, et al. Family-Focused treatment for adolescents with bipolar disorder: results of a 2-year randomized trial. Arch Gen Psychiatry 2008 Sep 1; 65 (9): 1053-61
99. March JS. Multidimensional anxiety scale for children. North Tonawanda (NY): Multi-Health Systems, 1998
100. Shaffer D, Scott M, Wilcox H, et al. The Columbia Suicide Screen: validity and reliability of a screen for youth suicide and depression. J AmAcad Child Adolesc Psychiatry 2004; 43 (1): 71-9 (Pubitemid 41615024)
101. Narayan V, Haddad PM. Antidepressant discontinuation manic states: a critical review of the literature and suggested diagnostic criteria. J Psychopharmacol 2011 Mar; 25 (3): 306-13